Kenneth Saag, MD, professor of medicine at University of Alabama at Birmingham, and Rheumatology Advisor advisory board member, discusses new pooled safety data for lesinurad for the treatment of gout recently presented at the ACR annual meeting in Washington, DC. 

Continue Reading

Follow Rheumatology Advisor’s continuing conference coverage by clicking here